Literature DB >> 1264072

An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic acid-polycytidylic acid and its mismatched analogues.

P O Ts'o, J L Alderfer, J Levy, L W Marshall, J O'Malley, J S Horoszewicz, W A Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1264072

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  10 in total

1.  Potentiated lymphokine-activated killer cell activity generated by low-dose interleukin-2 and mismatched double-stranded RNA.

Authors:  H R Hubbell; G D Gibson; R D Bigler
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  The mechanism of poly I:C-induced antiviral activity in peritoneal macrophage.

Authors:  S Pyo
Journal:  Arch Pharm Res       Date:  1994-04       Impact factor: 4.946

3.  Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection.

Authors:  K A Thompson; D R Strayer; P D Salvato; C E Thompson; N Klimas; A Molavi; A K Hamill; Z Zheng; D Ventura; W A Carter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

4.  Interferon induction by mismatched analogues of polyinosinic acid . polycytidylic acid [(Ix,U)n.(C)n].

Authors:  E De Clercq; G F Huang; B Bhooshan; G Ledley; P F Torrence
Journal:  Nucleic Acids Res       Date:  1979-12-11       Impact factor: 16.971

5.  Biologic effects after a single dose of poly(I):poly(C12U) in healthy volunteers.

Authors:  C W Hendrix; J B Margolick; B G Petty; R B Markham; L Nerhood; H Farzadegan; P O Ts'o; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

6.  Stimulation of natural killer cytotoxicity by long-term treatment with double-stranded polynucleotides without induction of hyporesponsiveness.

Authors:  D Nolibe; M N Thang
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  Induction of interferon by polyribonucleotides containing thiopyrimidines.

Authors:  K Reuss; K H Scheit; O Saiko
Journal:  Nucleic Acids Res       Date:  1976-10       Impact factor: 16.971

8.  Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.

Authors:  D A Stringfellow; S D Weed
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

9.  A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.

Authors:  David R Strayer; William A Carter; Bruce C Stouch; Staci R Stevens; Lucinda Bateman; Paul J Cimoch; Charles W Lapp; Daniel L Peterson; William M Mitchell
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

Review 10.  Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).

Authors:  William M Mitchell
Journal:  Expert Rev Clin Pharmacol       Date:  2016-06       Impact factor: 5.045
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.